The UK Government published its approach to veterinary medicines in NI on 19 June. These changes will require adaptation by holders of marketing authorisations for veterinary medicines and other NI operators.
The supply of veterinary medicines to NI is currently covered by a ‘grace period’ arrangement until 31 December 2025.
From 1 January 2026 the Windsor Framework rules governing the distribution of veterinary medicines in NI will apply in full.
From that date, in order to maintain NI’s full access to the EU’s single market, the movement of veterinary medicines into NI must comply with relevant EU rules.
Approximately 3,000 veterinary products are licenced for supply in NI. The report estimates that there will be very limited disruption to supply with 10% to 15% of authorised products expected to be discontinued.
The government considers fewer than 20 of these are likely to result in significant adverse impacts if not addressed. Government analysis suggests that where products have been indicated as being at particular risk of discontinuation, most are either not currently supplied or there is a suitable supply of alternative product authorised.
Challenges
UFU president William Irvine said: “a limited number of critical product discontinuations can still present serious challenges for animal health and welfare, and carry notable economic implications for our farming businesses. Our priority remains to ensure our farmers have the essential tools to manage their herds and flocks effectively. We have serious questions regarding the precise figures on product discontinuation and continue to seek clarification from government verses industry indications.”
From 1 January 2026, the government is introducing two schemes to enable NI vets to access medicine once the grace period ends.
A new Veterinary Medicines Health Situation Scheme permits the use of suitable alternative products from outside NI, by exception to the normal rules, if the situation of animal or public health so requires, in accordance with the Winsor Framework.
In addition, the Veterinary Medicines Internal Market Scheme will allow vets to use specific individual medicines not authorised or available in NI when needed.
British Veterinary Association President Dr Elizabeth Mullineaux said: “However, whilst the remedies provide some reassurances, the detail of how the schemes work for vets in Northern Ireland will be critical to understanding how effective they are in reality.”
SHARING OPTIONS: